$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

$lsta Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000032001714000070 Filed on October 30, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q4
Revenue	$5.276K	$4.118K	$4.078K
YoY Change	29.38%	11.09%	-99.85%
Cost Of Revenue	$4.210M	$4.012M	$3.390M
YoY Change	24.19%	34.83%	32.94%
Gross Profit	$1.070M	-$4.008M	$690.0K
YoY Change	55.07%	-648.34%	245.0%
Gross Profit Margin	20280.52%	-97334.9%	16920.06%
Selling, General & Admin	$6.450M	$7.894M	$5.890M
YoY Change	9.51%	42.05%	13.71%
% of Gross Profit	602.8%		853.62%
Research & Development	$10.14M	$8.470M	$5.290M
YoY Change	91.68%	88.78%	79.32%
% of Gross Profit	947.66%		766.67%
Depreciation & Amortization	$610.0K	$590.0K	$410.0K
YoY Change	48.78%	59.46%	5.13%
% of Gross Profit	57.01%		59.42%
Operating Expenses	$16.62M	$20.38M	$11.18M
YoY Change	48.66%	56.5%	37.35%
Operating Profit	-$15.55M	-$16.26M	-$10.49M
YoY Change	48.24%	74.58%	32.12%
Interest Expense	-$370.0K	$183.5K	-$70.00K
YoY Change	428.57%	86.05%	-68.18%
% of Operating Profit
Other Income/Expense, Net	$3.990M	-$870.8K	-$1.860M
YoY Change	-314.52%	-1175.18%	-57.24%
Pretax Income	-$11.69K	-$17.13M	-$12.72K
YoY Change	-8.08%	85.55%	-99.9%
Income Tax	-$250.0K	$47.39K	$290.0K
% Of Pretax Income
Net Earnings	-$11.61K	-$16.97K	-$12.54K
YoY Change	-7.36%	87.12%	-99.92%
Net Earnings / Revenue	-220.09%	-412.19%	-307.38%
Basic Earnings Per Share
Diluted Earnings Per Share	-$3.225M	-$4.835M	-$4.728M
COMMON SHARES
Basic Shares Outstanding	35.74M shares	35.25M shares	27.14M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.25M	$32.81M	$46.13M
YoY Change	-43.09%	94.12%	236.74%
Cash & Equivalents	$19.17M	$32.14M	$46.13M
Short-Term Investments	$7.080M	$665.1K	$0.00
Other Short-Term Assets	$6.900M	$6.500M	$2.900M
YoY Change	137.93%	225.0%	52.63%
Inventory		$2.142M	$1.270M
Prepaid Expenses
Receivables	$3.111M	$2.089M	$1.861M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$36.28M	$41.41M	$50.83M
YoY Change	-28.62%	103.64%	204.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.96M	$15.69M	$12.84M
YoY Change	24.26%	38.43%	15.16%
Goodwill	$25.21M	$25.21M	$11.12M
YoY Change	126.75%	126.75%	0.0%
Intangibles	$47.56M	$47.71M	$13.88M
YoY Change	242.76%	240.14%	-4.18%
Long-Term Investments
YoY Change
Other Assets	$1.263M	$1.317M	$1.152M
YoY Change	9.69%	35.32%	21.58%
Total Long-Term Assets	$89.99M	$89.92M	$38.99M
YoY Change	130.82%	140.12%	3.42%
TOTAL ASSETS
Total Short-Term Assets	$36.28M	$41.41M	$50.83M
Total Long-Term Assets	$89.99M	$89.92M	$38.99M
Total Assets	$126.3M	$131.3M	$89.82M
YoY Change	40.59%	127.28%	65.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.661M	$4.400M	$3.355M
YoY Change	68.74%	42.35%	31.3%
Accrued Expenses	$4.323M	$2.819M	$4.018M
YoY Change	7.59%	26.29%	75.86%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$200.0K
YoY Change	-100.0%	-100.0%	-94.12%
Long-Term Debt Due	$1.110M	$1.000M	$0.00
YoY Change		150.0%	-100.0%
Total Short-Term Liabilities	$16.24M	$11.85M	$9.807M
YoY Change	65.64%	18.12%	-1.43%
LONG-TERM LIABILITIES
Long-Term Debt	$13.89M	$15.00M	$0.00
YoY Change		4900.0%	-100.0%
Other Long-Term Liabilities	$804.5K	$616.0K	$598.7K
YoY Change	34.38%	20.34%	178.65%
Total Long-Term Liabilities	$68.20M	$15.62M	$27.79M
YoY Change	145.42%	23.78%	28.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.24M	$11.85M	$9.807M
Total Long-Term Liabilities	$68.20M	$15.62M	$27.79M
Total Liabilities	$68.20M	$69.28M	$27.79M
YoY Change	145.42%	205.85%	-11.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$291.2M	-$279.6M	-$236.4M
YoY Change	23.21%	24.93%	19.75%
Common Stock	$36.78K	$35.49K	$27.20K
YoY Change	35.25%	67.43%	66.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$705.7K	$705.7K	$705.7K
YoY Change	0.0%	1.58%	6.03%
Treasury Stock Shares
Shareholders Equity	$58.51M	$63.00M	$62.54M
YoY Change
Total Liabilities & Shareholders Equity	$126.3M	$131.3M	$89.82M
YoY Change	40.59%	127.28%	65.08%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q4
OPERATING ACTIVITIES
Net Income	-$11.61K	-$16.97K	-$12.54K
YoY Change	-7.36%	87.12%	-99.92%
Depreciation, Depletion And Amortization	$610.0K	$590.0K	$410.0K
YoY Change	48.78%	59.46%	5.13%
Cash From Operating Activities	-$10.91M	-$13.48M	-$7.360M
YoY Change	48.23%	103.93%	-23.49%
INVESTING ACTIVITIES
Capital Expenditures	-$730.0K	-$490.0K	-$1.740M
YoY Change	-58.05%	-27.94%	427.27%
Acquisitions
YoY Change
Other Investing Activities	-$6.460M	$250.0K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$7.190M	-$240.0K	-$1.740M
YoY Change	313.22%	-64.71%	-119.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.120M	13.00M	38.29M
YoY Change	-86.63%	36.55%	-2379.17%
NET CHANGE
Cash From Operating Activities	-10.91M	-13.48M	-7.360M
Cash From Investing Activities	-7.190M	-240.0K	-1.740M
Cash From Financing Activities	5.120M	13.00M	38.29M
Net Change In Cash	-12.98M	-720.0K	29.19M
YoY Change	-144.47%	-132.29%	-1258.33%
FREE CASH FLOW
Cash From Operating Activities	-$10.91M	-$13.48M	-$7.360M
Capital Expenditures	-$730.0K	-$490.0K	-$1.740M
Free Cash Flow	-$10.18M	-$12.99M	-$5.620M
YoY Change	81.14%	119.06%	-39.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3354908	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4400437	USD
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2088888	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1860835	USD
	us-gaap	Accretion Expense AccretionExpense	0	USD
	us-gaap	Accretion Expense AccretionExpense	7329	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	948644	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2925918	USD
CY2014Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	22430000	USD
CY2013Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	9473200	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4018026	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2818623	USD
CY2013Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4018000	USD
CY2014Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	2818600	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	544800	USD
CY2014Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	608200	USD
CY2014Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	100000	USD
CY2013Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	500000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	112	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	343308264	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	299594525	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3287900	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8941500	USD
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2127600	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5412500	USD
CY2014Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2088888	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1860835	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	453900	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	453900	USD
CY2014Q3	us-gaap	Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions	-2900000	USD
CY2013Q4	us-gaap	Assets Assets	89816082	USD
CY2014Q3	us-gaap	Assets Assets	131338677	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	41413941	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	50826750	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	0	USD
CY2014Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	665100	USD
CY2014Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	18482900	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	0	USD
CY2014Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	665100	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	18482900	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	18482900	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	18483000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	18483000	USD
CY2014Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	33500000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-5400000	USD
CY2014Q2	us-gaap	Business Combination Acquired Receivables Fair Value BusinessCombinationAcquiredReceivablesFairValue	45100	USD
	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	11890000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1090000	USD
CY2014Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1100000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	90000000	USD
CY2014Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	22430000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	11900000	USD
CY2014Q3	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	12400000	USD
	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	30000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46133759	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13737452	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16946200	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-13992473	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3208748	USD
CY2013Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	9450000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	51200	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	201000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	19200	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	333100	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent	13901200	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	34290000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	2014100	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	19400000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1040900	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	33490700	USD
CY2014Q3	us-gaap	Cash Cash	17817900	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	50894	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32141286	USD
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35485523	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27196537	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5329593	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35485523	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27196537	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	27197	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	35486	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-205844	USD
	us-gaap	Cost Of Revenue CostOfRevenue	11515168	USD
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	20407	shares
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	0	shares
	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	10000000	USD
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3639979	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1816601	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	4379226	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	18422575	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16975155	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26446692	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43261231	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9070757	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-514877	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-202375	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-319880	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-26766572	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-17177530	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-43776108	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9276601	USD
CY2014Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0.01	shares
CY2013Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0.01	shares
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	2975935	USD
	us-gaap	Cost Of Revenue CostOfRevenue	9603048	USD
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	4012369	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	100	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1578334	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1197801	USD
CY2013Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	23175	USD
CY2014Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.37
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.43
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	112	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	2325800	USD
CY2014Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1435600	USD
	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	300000	USD
CY2014Q2	us-gaap	Equity Issued In Business Combination Fair Value Disclosure EquityIssuedInBusinessCombinationFairValueDisclosure	21600000	USD
CY2014Q3	us-gaap	Fair Value Estimate Not Practicable Investments FairValueEstimateNotPracticableInvestments	18483000	USD
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	1090000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1893400	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2347300	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	45139600	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	151300	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	605200	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	605200	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	605200	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	605200	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50059000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15769000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47711700	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13875600	USD
CY2014Q3	us-gaap	Goodwill Goodwill	25209336	USD
CY2013Q4	us-gaap	Goodwill Goodwill	11117770	USD
CY2014Q2	us-gaap	Goodwill Goodwill	14091700	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2014Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15000000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-205844	USD
CY2014Q3	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	-300000	USD
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-514877	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-202375	USD
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-319880	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9231844	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43634037	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26274247	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17129257	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	492325	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44757	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	142183	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47387	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	108363	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	177162	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-142183	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-492325	USD
CY2014Q3	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	600000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1823379	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-446399	USD
CY2014Q3	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	-1500000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-583659	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	872079	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-559470	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-421	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	663543	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2795249	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13875617	USD
CY2014Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47711709	USD
	us-gaap	Interest Expense InterestExpense	383539	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	98618	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	183477	USD
	us-gaap	Interest Expense InterestExpense	208023	USD
	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	17708	USD
	us-gaap	Interest Paid InterestPaid	202800	USD
CY2014Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	956515	USD
	us-gaap	Interest Paid InterestPaid	359300	USD
CY2014Q3	us-gaap	Inventory Net InventoryNet	2142302	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	1270223	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	8941452	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	5412451	USD
CY2014Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
CY2013Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	900000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	900000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	27789647	USD
CY2014Q3	us-gaap	Liabilities Liabilities	69279705	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	131338677	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	89816082	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9806919	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11854615	USD
CY2014Q3	us-gaap	Long Term Debt LongTermDebt	19500000	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	5500000	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	5700000	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5700000	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2400000	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	200000	USD
CY2013Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	531164	USD
CY2014Q3	us-gaap	Marketable Securities MarketableSecurities	665112	USD
CY2013Q4	us-gaap	Marketable Securities MarketableSecurities	0	USD
CY2014Q3	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	18483000	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	-516040	USD
CY2014Q3	us-gaap	Minority Interest MinorityInterest	-944300	USD
CY2014Q3	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.100
CY2011Q1	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.199
CY2014Q3	us-gaap	Mortgage Loans On Real Estate Carrying Amount Of Mortgages MortgageLoansOnRealEstateCarryingAmountOfMortgages	3100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23895091	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25546121	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3547353	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-948644	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19737699	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35991241	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9070757	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16974269	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-43261343	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26446692	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-870757	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1446107	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1151729	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1317082	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	112	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-886	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Operating Expenses OperatingExpenses	54850220	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	13019749	USD
	us-gaap	Operating Expenses OperatingExpenses	36904622	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-16258500	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9312831	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-42187930	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-26314385	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3206400	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	7000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	40138	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	80987	USD
CY2014Q3	us-gaap	Notes Payable NotesPayable	2000000	USD
CY2013Q4	us-gaap	Notes Payable NotesPayable	900000	USD
CY2013Q4	us-gaap	Notes Payable Current NotesPayableCurrent	381097	USD
CY2014Q3	us-gaap	Notes Payable Current NotesPayableCurrent	995576	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	20376283	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	699800	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	999900	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1162500	USD
CY2013Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	110600000	USD
CY2014Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	674800	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	647400	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-886	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	112	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	598729	USD
CY2014Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	616000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1062568	USD
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	179605	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	248161	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-687280	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	100000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	920329	USD
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2014Q3	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1561933	USD
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4376353	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	11700000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	14476170	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	11275109	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	21517422	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1777163	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	709741	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	248000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	86658	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	271008	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2126291	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1720725	USD
	us-gaap	Profit Loss ProfitLoss	-43776220	USD
	us-gaap	Profit Loss ProfitLoss	-26766572	USD
CY2013Q3	us-gaap	Profit Loss ProfitLoss	-9276601	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	-17176644	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15686609	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12844216	USD
CY2014Q3	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	337200	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	737333	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	332713	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	3236721	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	150294	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4486389	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8469623	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19024728	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11619843	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-279634948	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-236373605	USD
	us-gaap	Revenues Revenues	10590237	USD
CY2013Q3	us-gaap	Revenues Revenues	3706918	USD
	us-gaap	Revenues Revenues	12662290	USD
CY2014Q3	us-gaap	Revenues Revenues	4117783	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5412451	USD
CY2014Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	0	USD
CY2013Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	213112	USD
CY2013Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	3023609	USD
CY2014Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	0	USD
CY2014Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	20000000	USD
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5557425	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24310324	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15681731	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7894291	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3545956	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1658100	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	580900	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	561200	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	403900	USD
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	0	USD
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	70500	USD
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	452454	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	708706	shares
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	21600351	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11275109	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	21517422	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	4964000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2967700	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8941452	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	62542475	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	63003272	USD
CY2014Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	62058972	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	18482413	shares
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	62026435	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32820159	USD
CY2013Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35134395	USD
CY2014Q3	us-gaap	Treasury Stock Value TreasuryStockValue	705742	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	705742	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	23175	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-12952	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	31663221	shares
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20203934	shares
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35053218	shares
CY2014Q3	nbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	273200	USD
CY2013Q4	nbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	1811000	USD
CY2014Q3	nbs	Aggregate Intrinsic Value Warrantsvested AggregateIntrinsicValueWarrantsvested	273200	USD
CY2014Q3	nbs	Aggregate Intrinsic Value Warrantsvestedandexpectedtovest AggregateIntrinsicValueWarrantsvestedandexpectedtovest	273200	USD
	nbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
	nbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
	nbs	Clinical Services Reimbursement ClinicalServicesReimbursement	2800000	USD
	nbs	Clinical Services Reimbursement ClinicalServicesReimbursement	1400000	USD
CY2013Q3	nbs	Clinical Services Reimbursement ClinicalServicesReimbursement	600000	USD
CY2014Q3	nbs	Clinical Services Reimbursement ClinicalServicesReimbursement	1000000	USD
CY2013Q4	nbs	Common Stock Warrants Shares CommonStockWarrantsShares	4898266	shares
CY2014Q3	nbs	Common Stock Warrants Shares CommonStockWarrantsShares	3555956	shares
	nbs	Commonstockandcontingentconsiderationissuedinmerger Commonstockandcontingentconsiderationissuedinmerger	0	USD
	nbs	Commonstockandcontingentconsiderationissuedinmerger Commonstockandcontingentconsiderationissuedinmerger	33490351	USD
	nbs	Expiration Expiration	23200	USD
	nbs	Payment For Warrant Inducement PaymentForWarrantInducement	62014	USD
	nbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	780100	USD
	nbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-2483740	USD
	nbs	Payment For Warrant Inducement PaymentForWarrantInducement	0	USD
CY2011Q4	nbs	Percentageof Net Sales PercentageofNetSales	0.10
CY2011Q4	nbs	Percentageoflicensecost Percentageoflicensecost	0.30
CY2013Q4	nbs	Preferred Stock Shares Designated PreferredStockSharesDesignated	825000	shares
CY2014Q3	nbs	Preferred Stock Shares Designated PreferredStockSharesDesignated	825000	shares
	nbs	Provision For Reduction Of Doubtful Accounts ProvisionForReductionOfDoubtfulAccounts	232531	USD
	nbs	Provision For Reduction Of Doubtful Accounts ProvisionForReductionOfDoubtfulAccounts	5763	USD
CY2014Q3	nbs	Sharesvestedandexpectedtovest Sharesvestedandexpectedtovest	3555956	shares
	nbs	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	2126291	USD
	nbs	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	1720725	USD
CY2014Q3	nbs	Stock Option Exercise StockOptionExercise	48987	shares
CY2014Q3	nbs	Subsidiary Ownership Interest By Parent SubsidiaryOwnershipInterestByParent	0.900
CY2011Q1	nbs	Subsidiary Ownership Interest By Parent SubsidiaryOwnershipInterestByParent	0.801
	nbs	Warrants Exercised WarrantsExercised	333250	shares
	nbs	Warrants Expired WarrantsExpired	100108	shares
	nbs	Warrants Granted WarrantsGranted	2722	shares
	nbs	Weighted Average Estimated Fair Value Of Restricted Stock WeightedAverageEstimatedFairValueOfRestrictedStock	6.56
	nbs	Weighted Average Estimated Fair Value Of Restricted Stock WeightedAverageEstimatedFairValueOfRestrictedStock	7.00
	nbs	Weighted Average Exercise Price Warrants Canceled WeightedAverageExercisePriceWarrantsCanceled	23.97
CY2014Q3	nbs	Weighted Average Exercise Price Warrants Exercisable WeightedAverageExercisePriceWarrantsExercisable	14.15
	nbs	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised	5.16
	nbs	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	70.00
	nbs	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	12.26
CY2013Q4	nbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	16.50
CY2014Q3	nbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	14.13
CY2013Q4	nbs	Warrant Derivative Liabilities WarrantDerivativeLiabilities	23200	USD
CY2014Q3	nbs	Warrant Derivative Liabilities WarrantDerivativeLiabilities	0	USD
	nbs	Warrant Inducements WarrantInducements	62014	USD
	nbs	Warrants Canceled WarrantsCanceled	911674	shares
CY2014Q3	nbs	Weighted Average Exercise Price Warrantsvestedexpectedtovest WeightedAverageExercisePriceWarrantsvestedexpectedtovest	14.13
	nbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P2Y4M13D
CY2013	nbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P2Y7M17D
	nbs	Weighted Average Remaining Contractual Termwarrantsvested WeightedAverageRemainingContractualTermwarrantsvested	P2Y4M13D
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000320017
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35738358	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	NeoStem, Inc.

Files In Submission

Name	View Source	Status
0000320017-14-000070-index-headers.html	Edgar Link	pending
0000320017-14-000070-index.html	Edgar Link	pending
0000320017-14-000070.txt	Edgar Link	pending
0000320017-14-000070-xbrl.zip	Edgar Link	pending
exhibit104_vaczy.htm	Edgar Link	pending
exhibit105_dickey.htm	Edgar Link	pending
exhibit106_preti.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
nbs-10qx20140930.htm	Edgar Link	pending
nbs-20140930.xml	Edgar Link	completed
nbs-20140930.xsd	Edgar Link	pending
nbs-20140930_cal.xml	Edgar Link	unprocessable
nbs-20140930_def.xml	Edgar Link	unprocessable
nbs-20140930_lab.xml	Edgar Link	unprocessable
nbs-20140930_pre.xml	Edgar Link	unprocessable
nbs-ex311_20140930xq3.htm	Edgar Link	pending
nbs-ex312_20140930xq3.htm	Edgar Link	pending
nbs-ex321_20140930xq3.htm	Edgar Link	pending
nbs-ex322_20140930xq3.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

2014 Q4 Form 10-Q Financial Statement

#000032001714000070 Filed on October 30, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA LISATA THERAPEUTICS, INC. Stock $lsta

2014 Q4 Form 10-Q Financial Statement

#000032001714000070 Filed on October 30, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta